0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
8 Ansichten28 Seiten
Neonatal encephalopathy is a clinical term describing an abnormal neurological state in newborns, often involving altered consciousness and signs of brainstem or motor dysfunction. It can be caused by hypoxic ischemic encephalopathy, stroke, kernicterus, metabolic issues, hemorrhage, infection or toxins. Diagnosis involves abnormal neurological exam findings within days of birth. Treatment focuses on stabilization, seizures, hypotension, hypoglycemia and supportive care. Therapeutic hypotherapy improves outcomes for moderate to severe cases, reducing death and disability. Outcomes depend on the extent and location of brain damage, with possible complications including cerebral palsy, developmental delays or death.
Neonatal encephalopathy is a clinical term describing an abnormal neurological state in newborns, often involving altered consciousness and signs of brainstem or motor dysfunction. It can be caused by hypoxic ischemic encephalopathy, stroke, kernicterus, metabolic issues, hemorrhage, infection or toxins. Diagnosis involves abnormal neurological exam findings within days of birth. Treatment focuses on stabilization, seizures, hypotension, hypoglycemia and supportive care. Therapeutic hypotherapy improves outcomes for moderate to severe cases, reducing death and disability. Outcomes depend on the extent and location of brain damage, with possible complications including cerebral palsy, developmental delays or death.
Neonatal encephalopathy is a clinical term describing an abnormal neurological state in newborns, often involving altered consciousness and signs of brainstem or motor dysfunction. It can be caused by hypoxic ischemic encephalopathy, stroke, kernicterus, metabolic issues, hemorrhage, infection or toxins. Diagnosis involves abnormal neurological exam findings within days of birth. Treatment focuses on stabilization, seizures, hypotension, hypoglycemia and supportive care. Therapeutic hypotherapy improves outcomes for moderate to severe cases, reducing death and disability. Outcomes depend on the extent and location of brain damage, with possible complications including cerebral palsy, developmental delays or death.
ID: 434300426 SUPERVISION: DR. Majedah AL- razzaz Objective • Defination • Etiology and risk factor • Incidence • Pathophysiology • Clinical manifestations • Diagnosis • Assessment tools • Treatment • Therapeutic hypothermia • Outcomes What is neonatal encephalopathy (NE)?
• Is a clinical and not an etiologic term that describes
an abnormal neurobehavioral state cosisting of an altered level of consciousness usually other signs of brainstem and or motor dysfunction. Causes of neonatal encephalopathy
• Hypoxic ischemic encephalopathy
• Perinatal stroke • Kernicterus • Metabolic derangements (inborn errors of metabolism or hypoglycemia ) • Intracranial hemorrhage • Infection • Maternal toxins Etiology of HIE Fetal factors Uteroplacental factors Maternal factors
hemorrhage •Cord prolapse •Asphyxiation •Twin to twin transfusion •Uterine rupture •Sever anaphylaxis •Severe isoimmune •Hyper stimulation with •Status epilepticus hemolytic DX oxytocic agents •Hypovolemic shock •Cardiac arrhythmia •Pre eclamsia •IUGR INCIDENCE OF HIE • Occurs in 1-6 per 1000 live term births • Approximately 20-30% of infants with HIE die in the neonatal period • 33-50% of survivors are left with permanent neurodevelopmental abnormalities (cerebral palsy or mental retardation ) Pathophysiology Cont… • Gestational age plays an important role: • < 20 weeks – insult leads to neuronal heterotopia or polymicrogyria • 26-36 weeks --- insult affects white matter leading to periventricular leukomalacia • Term – insult affects primarily gray matter Clinical picture 1. Neurological signs : Abnormal findings on neurologic exam in the first few days after birth is the single most useful predictor that brain insult has occurred in the perinatal period . 2. Multiorgan dysfunction Diagnosis • There is no clear diagnostic test for HIE Abnormal findings on the neurologic exam in the first few days after birth is the single most useful predictor that brain insult has occurred in the perinatal period Criteria for diagnosis of HIE 1. Metabolic acidosis (cord PH less than 7 or base deficit of more than 12) 2. Early onset of encephalopathy 3. Multisystem organ dysfunction 4. 5 min apgar less than 4 Clinical staging of HIE Assessment tools (investigations) • Prenatal : Doppler ultrasound (assess the cord blood flow) • Perinatal : Blood gas analysis • Postnatal : Monitoring of ABG –blood glucose serum electrolytes – temperature – serum calcium –renal function – LFT CONT.. • Neuroimaging : Amplitude-integrated EEG (aEEG) it reflect dysfunction rather than permanent injury Also it useful in infans who have moderate to severe encephalopathy So if the aEEG— normal the outcome is good But if abnormal --- it raises the probability of death or sever disability from 25%to 75% Cont.. • MRI : Most appropriate technique and is able to show different patterns of injury Treatment 1. Proper stabilization to minimize neuronal damage
2. Treatment of seizure by anticonvulsant
3. Treatment of hypotension by volume and inotropic support 4. Treatment of hypoglycaemia and hypocalcemia Emerging therapies • Xenon – inhibits excitatory amino acid relese and easily crosses blood – brain barrier • Erythropoietin – possible neuroprotection against apoptosis , anti inflammatory effect • Melatonin – inhibit free radical , decreases inflammatory cytokine level and stimulates antioxidant enzymes Treatment of complications CNS complicatons management • Monitor systemic blood pressure ,intracranial pressure (by feel of fontanel) and structural changes or damage (usually MRI) • Pharmacologically management : anticonvulsants (phenobarbiton , phenytoin) ,sedation especially if ventilated and cooled (morphine, midazolam) • Prevent fluid overloading Cardiovascular and renal complications • hypovolaemia, hypotension , renal failure are most serious sequelae of HIE and need to monitor --- urine output, monitor electolyes, urea , creatinine • hypovolaemia, hypotension ---management with volume expanders ,blood transfusion and –or inotrops (improve cardiac contractility and cardiac output also improve renal function ) Pulmonary complication management • Monitor respiratory status by observation and blood gases • Provide respiratory support if required (CPAP or ventilation) • Treat underlying pathology Metabolic complication management • Metabolic acidosis – (ventilate and use sodium bicarbonate ). • Hypoglycaemia (10% dextrose ), hypocalcaemia correction • Monitor BP Outcomes • The location and extent of damage , and the immediate medical management will determine the short and long term outcomes. • Its possible to have no long term complication • But complication that can occur are delayed as failure to reach milestone , cerebral palsy , death .